The Parkinson's disease gene PINK1 activates Akt via PINK1 kinase-dependent regulation of the phospholipid PI(3,4,5)P3

被引:27
|
作者
Furlong, Rachel M. [1 ,2 ,3 ]
Lindsay, Andrew [1 ]
Anderson, Karen E. [4 ]
Hawkins, Phillip T. [4 ]
Sullivan, Aideen M. [2 ,3 ]
O'Neill, Cora [1 ,3 ]
机构
[1] Univ Coll Cork, Sch Biochem & Cell Biol, Biosci Inst, Cork T12 YT20, Ireland
[2] Univ Coll Cork, Dept Anat & Neurosci, Western Gateway Bldg, Cork T12 XF62, Ireland
[3] Univ Coll Cork, Cork NeuroSci Ctr, Cork T12 YT20, Ireland
[4] Babraham Inst, Signalling Programme, Cambridge CB22 3AT, England
基金
英国生物技术与生命科学研究理事会;
关键词
Akt; Parkinson's disease; PINK1; neurodegeneration; PIP3; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASE-1; GOLGI FRAGMENTATION; TUMOR-SUPPRESSOR; MITOCHONDRIAL DEPOLARIZATION; RECEPTOR TRAFFICKING; POSITIVE REGULATION; OXIDATIVE STRESS; SAC1; DOMAIN; CELL-DEATH; PHOSPHORYLATION;
D O I
10.1242/jcs.233221
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Akt signalling is central to cell survival, metabolism, protein and lipid homeostasis, and is impaired in Parkinson's disease (PD). Akt activation is reduced in the brain in PD, and by many PD-causing genes, including PINK1. This study investigated the mechanisms by which PINK1 regulates Akt signalling. Our results reveal for the first time that PINK1 constitutively activates Akt in a PINK1-kinase dependent manner in the absence of growth factors, and enhances Akt activation in normal growth medium. In PINK1-modified MEFs, agonist-induced Akt signalling failed in the absence of PINK1, due to PINK1 kinase-dependent increases in PI(3,4,5)P-3 at both plasma membrane and Golgi being significantly impaired. In the absence of PINK1, PI(3,4,5)P-3 levels did not increase in the Golgi, and there was significant Golgi fragmentation, a recognised characteristic of PD neuropathology. PINK1 kinase activity protected the Golgi from fragmentation in an Akt-dependent fashion. This study demonstrates a new role for PINK1 as a primary upstream activator of Akt via PINK1 kinase-dependent regulation of its primary activator PI(3,4,5)P-3, providing novel mechanistic information on how loss of PINK1 impairs Akt signalling in PD. This article has an associated First Person interview with the first author of the paper.
引用
收藏
页数:16
相关论文
共 50 条
  • [41] Exploring the contribution of the mitochondrial disulfide relay system to Parkinson's disease: the PINK1/CHCHD4 interplay
    Giuseppe Arena
    Nazanine Modjtahedi
    Rejko Kruger
    Neural Regeneration Research, 2021, 16 (11) : 2222 - 2224
  • [42] Exploring the contribution of the mitochondrial disulfide relay system to Parkinson's disease: the PINK1/CHCHD4 interplay
    Arena, Giuseppe
    Modjtahedi, Nazanine
    Kruger, Rejko
    NEURAL REGENERATION RESEARCH, 2021, 16 (11) : 2222 - 2224
  • [43] PI(3,4,5)P3 engagement restricts Akt kinase activity to cellular membranes.
    Ebner, M.
    Lucic, I.
    Leonard, T.
    Yudushkin, I.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
  • [44] A common A340T variant in PINK1 gene associated with late-onset Parkinson's disease in Chinese
    Wang, Feng
    Feng, Xiuli
    Ma, Jinhong
    Zou, Haiqiang
    Chan, Piu
    NEUROSCIENCE LETTERS, 2006, 410 (02) : 121 - 125
  • [45] Evidence for Early and Progressive Ultrasonic Vocalization and Oromotor Deficits in a PINK1 Gene Knockout Rat Model of Parkinson's Disease
    Grant, Laura M.
    Kelm-Nelson, Cynthia A.
    Hilby, Breanna L.
    Blue, Katherine V.
    Rajamanickam, Eunice S. Paul
    Pultorak, Joshua D.
    Fleming, Shelia M.
    Ciucci, Michelle R.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2015, 93 (11) : 1713 - 1727
  • [46] FGD5-AS1/miR-5590-3p/PINK1 induces Lenvatinib resistance in hepatocellular carcinoma
    Song, Meifang
    Ma, Luyuan
    Shen, Chuan
    Liu, Wenpeng
    Zhang, Pengfei
    Bi, Ranran
    Zhao, Caiyan
    CELLULAR SIGNALLING, 2023, 111
  • [47] A Novel PINK1 p.F385S Loss-of-Function Mutation in an Indian Family with Parkinson's Disease
    Sharma, Karan
    Kishore, Asha
    Lechado-Terradas, Anna
    Passannanti, Raffaele
    Raimondi, Francesco
    Sturm, Marc
    Sreelatha, Ashwin Ashok Kumar
    Puthenveedu, Divya Kalikavila
    Sarma, Gangadhara
    Casadei, Nicolas
    Krueger, Rejko
    Gasser, Thomas
    Kahle, Philipp
    Riess, Olaf
    Fitzgerald, Julia C.
    Sharma, Manu
    MOVEMENT DISORDERS, 2024, 39 (07) : 1217 - 1225
  • [48] Inhibition of dynamin-related protein 1 ameliorates the mitochondrial ultrastructure via PINK1 and Parkin in the mice model of Parkinson's disease
    Feng, Si-Tong
    Wang, Zhen-Zhen
    Yuan, Yu-He
    Wang, Xiao-Le
    Guo, Zhen-Yu
    Hu, Jing-Hong
    Yan, Xu
    Chen, Nai-Hong
    Zhang, Yi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 907
  • [49] MUL1-A New Potential for a Therapeutic Target for Parkinson's Disease a Commentary on "MUL1 Acts in Parallel to the PINK1/Parkin Pathway in Regulating Mitofusin and Compensates for Loss of PINK1/Parkin" by Yun and Colleagues (eLife 2014; 3: 1-26)
    Olszewska, Diana A.
    Lynch, Tim
    MOVEMENT DISORDERS, 2016, 31 (07) : 1073 - 1073
  • [50] FOXO3a-dependent regulation of Pink1 (Park6) mediates survival signaling in response to cytokine deprivation
    Mei, Yang
    Zhang, Yiru
    Yamamoto, Kazuo
    Xie, Wei
    Mak, Tak W.
    You, Han
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) : 5153 - 5158